Dr. Don Jarvis

Department of Molecular Biology

Research Support:

1. Current research support
   1. NIH R01 AI124804 (to U.W., P.I. Jarvis) "Impact of Fc N-glycan structure on HIV-specific antibody functions".
      08-01-16 to 07-31-21.
   2. NIH R44 GM102982-03 (to GlycoBac with subcontract to UW, MPI's Blair and Jarvis) "Glycoengineering insect cells for commercial biologics manufacturing".
      04-01-16 to 08-31-21.
   3. NIH R43 GM125397 (to GlycoBac with subcontract to UW, MPI's Blair and Jarvis) "Engineering a new insect cell line for human-type protein glycosylation".
      04-01-18 to 03-31-21.
   4. NIH 1 R01 GM130969 (to Notre Dame with subcontract to UW, MPI's Fraser and Jarvis). "Engineering optimized N-glycosylation in the silkworm silk gland protein expression system".
      05-01-20 to 04-30-23 (UW subcontract total $338,256).
   5. NIH R43 GM136071 (to GlycoBac with subcontract to UW, MPI's Blair and Jarvis). "Insect cell lines for glycoprotein structural biology and mannose-dependent protein drugs".
      03-01-20 to 02-28-22.
   6. UW Science Initiative Faculty Innovation Seed Grant Program (UW to P.I. Jarvis) "Impact of a viral contaminant on biosafety profile of the baculovirus-insect cell system".
      3/01/19 to 6/30/21.
2. Pending research support:
   1. DoD Phase II SBIR (to Echelon Biosciences with subcontract to GlycoBac, P.I. Nielsen). "Active BChE".
      04-03-21 to 3-30-23.

 

(Last update 3/8/21)